142 related articles for article (PubMed ID: 6697455)
1. Effect of heparin on plasma fibrinopeptide A in patients with acute myocardial infarction.
Mombelli G; Im Hof V; Haeberli A; Straub PW
Circulation; 1984 Apr; 69(4):684-9. PubMed ID: 6697455
[TBL] [Abstract][Full Text] [Related]
2. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator.
Rapold HJ; Kuemmerli H; Weiss M; Baur H; Haeberli A
Circulation; 1989 May; 79(5):980-9. PubMed ID: 2496939
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina.
Mombelli G; Marchetti O; Haeberli A; Straub PW
Am Heart J; 1998 Dec; 136(6):1106-13. PubMed ID: 9842027
[TBL] [Abstract][Full Text] [Related]
5. Persistent generation of thrombin after acute myocardial infarction.
Szczeklik A; Dropinski J; Radwan J; Krzanowski M
Arterioscler Thromb; 1992 May; 12(5):548-53. PubMed ID: 1576116
[TBL] [Abstract][Full Text] [Related]
6. Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study Group.
Rapold HJ; de Bono D; Arnold AE; Arnout J; De Cock F; Collen D; Verstraete M
Circulation; 1992 Mar; 85(3):928-34. PubMed ID: 1537129
[TBL] [Abstract][Full Text] [Related]
7. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Murakoshi T
Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
[TBL] [Abstract][Full Text] [Related]
8. Thrombin activity during hemodialysis; evaluated by the fibrinopeptide A assay. A comparison between a high and a low heparin dose regime.
Wilhelmsson S; Ivemark CK; Kudryk B; Robinson D; Biberfeldt P
Thromb Res; 1983 Sep; 31(5):685-93. PubMed ID: 6648899
[TBL] [Abstract][Full Text] [Related]
9. [Fibrinogen metabolism and plasma fibrinopeptide A in disseminated neoplasms].
Mombelli G; Roux A; Hofmann V; Straub PW
Schweiz Med Wochenschr; 1979 Dec; 109(47):1901. PubMed ID: 531571
[TBL] [Abstract][Full Text] [Related]
10. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
Mombelli G; Monotti R; Haeberli A; Straub PW
Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias.
Mombelli G; Roux A; Haeberli A; Straub PW
Blood; 1982 Aug; 60(2):381-8. PubMed ID: 7093524
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal fibrin-formation and its inhibition in CAPD.
Gries E; Paar D; Graben N; Bock KD
Clin Nephrol; 1986 Oct; 26(4):209-12. PubMed ID: 3780071
[TBL] [Abstract][Full Text] [Related]
13. Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus.
Rosove MH; Frank HJ; Harwig SS
Diabetes Care; 1984; 7(2):174-9. PubMed ID: 6203689
[TBL] [Abstract][Full Text] [Related]
14. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
Herren T; Straub PW; Haeberli A
Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
[TBL] [Abstract][Full Text] [Related]
15. Measurement of fibrinopeptide A in the evaluation of heparin activity and fibrin formation during hemodialysis.
Wilhelmsson S; Asaba H; Gunnarsson B; Kudryk B; Robinson D; Bergström J
Clin Nephrol; 1981 May; 15(5):252-8. PubMed ID: 7249422
[TBL] [Abstract][Full Text] [Related]
16. Fibrinopeptide A excretion in urine in patients with atherosclerotic artery disease.
Gallino A; Haeberli A; Straub PW
Thromb Res; 1985 Jul; 39(2):237-44. PubMed ID: 4024054
[TBL] [Abstract][Full Text] [Related]
17. Significance of plasma fibrinopeptide A (fpA) in patients with malignancy.
Peuscher FW; Cleton FJ; Armstrong L; Stoepman-van Dalen EA; van Mourik JA; van Aken WG
J Lab Clin Med; 1980 Jul; 96(1):5-14. PubMed ID: 7391657
[TBL] [Abstract][Full Text] [Related]
18. Fibrinopeptide A: a marker of acute coronary thrombosis.
Eisenberg PR; Sherman LA; Schectman K; Perez J; Sobel BE; Jaffe AS
Circulation; 1985 May; 71(5):912-8. PubMed ID: 3986981
[TBL] [Abstract][Full Text] [Related]
19. Fibrinopeptide a (FPA) in patients with acute myocardial infarction.
Johnsson H; Orinius E; Paul C
Thromb Res; 1979; 16(1-2):255-60. PubMed ID: 505421
[No Abstract] [Full Text] [Related]
20. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
